本研究针对门诊宫腔镜肌瘤切除术中疼痛管理的关键问题，通过随机对照试验比较了标准技术（含宫颈旁阻滞）与阴道镜技术（无器械接触）在5.5?mm MyoSure宫腔镜手术中的应用效果。研究发现标准技术组疼痛评分显著更低（VAS 4.0 vs 5.9，p=0.001），而手术时间 ...

During a live surgical webcast originating at Springhill Medical Center, gynecologic surgeons from all over the world will have the unique opportunity to view a hysteroscopic myomectomy, featuring the ...

Hologic, Inc. HOLX recently announced the launch of new Fluent fluid management system in the United States. Per the company, this system is embedded with features that simplify and improvise the ...

Hologic’s HOLX GYN Surgical segment posted fourth-quarter revenues of $172.5 million, up 10.2% year over year. This marked the strongest growth in fiscal 2025, as the company had earlier anticipated, ...

A new device introduced at the recent American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting in Washington, D.C. has the potential to offer relief to women ...

MARLBOROUGH, Massachusetts, Jan. 3, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the MyoSure ® MANUAL device, which was designed to simplify tissue removal procedures ...

In line with Hologic, Inc. 's HOLX focus to grow within the promising space of GYN Surgical, it recently came up with a significant breakthrough. The company has made the U.S. launch of its Omni ...

--Designed to Simplify Intrauterine Tissue Removal In Theater and In-Office-- MARLBOROUGH, Massachusetts, Jan. 3, 2018 /PRNewswire/ --Hologic, Inc. (Nasdaq: HOLX) announced today that the MyoSure ...

In line with Hologic, Inc.’s (NASDAQ:HOLX) focus to grow within the promising space of GYN Surgical, the company recently announced encouraging global regulatory approvals for its Omni hysteroscope.